About 3.6 Million Medicare Beneficiaries Could Be Eligible for Wegovy Coverage, Study Shows About 3.6 Million Medicare Beneficiaries Could Be Eligible for Wegovy Coverage, Study Shows
About 3.6 million overweight or obese patients with heart conditions insured under the U.S. Medicare program could be eligible for coverage of Novo Nordisk ' s weight-loss...Reuters Health Information (Source: Medscape Internal Medicine Headlines)
Source: Medscape Internal Medicine Headlines - April 24, 2024 Category: Internal Medicine Tags: Diabetes & Endocrinology News Source Type: news
‘Kinder’ treatment for childhood brain cancer to be offered by NHS in England
Dabrafenib with trametinib can halt growth of some tumours for more than three times as long as standard chemotherapy, study showsThe NHS is to offer children with brain tumours in England a groundbreaking new targeted drug therapy to tackle the disease – a development charities are hailing as the biggest breakthrough in decades.Gliomas are the most common type of brain cancer in children but experts say the standard treatment of chemotherapy can be brutal and gruelling, and also carries the risk of side-effects such as weight loss, seizures and headaches.Continue reading... (Source: Guardian Unlimited Science)
Source: Guardian Unlimited Science - April 24, 2024 Category: Science Authors: Andrew Gregory Health editor Tags: Cancer Children's health National Institute for Health and Care Excellence England NHS UK news Society Medical research Science Source Type: news
Doctors issue 'Ozempic babies' alert over the risk of weight-loss jabs used by women hoping to become pregnant causing birth defects
A spate of women reported unexpectedly getting pregnant after being prescribed medications containing semaglutide, the key ingredient in drugs Wegovy and Ozempic. (Source: the Mail online | Health)
Source: the Mail online | Health - April 23, 2024 Category: Consumer Health News Source Type: news
Beyond weight loss: Five Yale experts on the benefits of exercise
Five Yale physicians in areas ranging from infectious diseases to allergy and immunology discuss why exercise is key to optimal health. (Source: Yale Science and Health News)
Source: Yale Science and Health News - April 23, 2024 Category: Universities & Medical Training Source Type: news
THIRTEEN new Ozempic-like drugs are coming in the next few years as part of weight-loss goldrush
Drugmakers like Novo Nordisk and Amgen are capitalizing on the success of groundbreaking obesity drugs with plans to release an additional 13 treatments in the coming years. (Source: the Mail online | Health)
Source: the Mail online | Health - April 23, 2024 Category: Consumer Health News Source Type: news
ACP: Time-Restricted Eating May Not Aid Weight Loss, Glycemic Measures
TUESDAY, April 23, 2024 -- Time-restricted eating (TRE) is not associated with weight loss or glycemic improvements compared with a usual eating pattern (UEP) when calories are held constant in both groups, according to a study published online... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - April 23, 2024 Category: Pharmaceuticals Source Type: news
Semaglutide Improves Knee OA Pain, Physical Function Semaglutide Improves Knee OA Pain, Physical Function
Results of the STEP 9 study in people with knee OA and obesity show that semaglutide not only induced significant weight loss but also improved knee pain and physical function.Medscape Medical News (Source: Medscape FamilyMedicine Headlines)
Source: Medscape FamilyMedicine Headlines - April 23, 2024 Category: Primary Care Tags: Rheumatology News Source Type: news
NHS-backed way to lose nearly 9lbs in 12 weeks (and no, it doesn't involve a diet of soups and shakes!)
Diet and exercise really do work, according to the results of an NHS weight loss programme. Health leaders said its success shows how it will become a 'vital tool' in helping people lose weight. (Source: the Mail online | Health)
Source: the Mail online | Health - April 22, 2024 Category: Consumer Health News Source Type: news
Weight-Loss Drugs Are Dragging Down Snack Makers ’ Bottom Line
Are you sure you’re not feeling even a little peckish? For people living with diabetes or obesity — two of the biggest health concerns in the US — the immensely popular group of weight loss medications called GLP-1s can be a miracle drug. But for restaurants, snack brands, alcohol makers, and fast…#glp1s #novonordisksozempic #elilillys #wendys #hershey #molsoncoors #halloffame #simplygoodfoods #chipotle #mcdonalds (Source: Reuters: Health)
Source: Reuters: Health - April 21, 2024 Category: Consumer Health News Source Type: news
Most people on weight loss drugs are spending less on restaurants and takeout, survey says
A highly popular group of weight loss and diabetes drugs is decreasing some consumers' appetites — and also how much they spend on food. Most people taking those medications, called GLP-1s, say they are spending less on eating out at restaurants and ordering takeout, according to a Morgan Stanley…#glp1s #hershey #novonordisk #elililly #glp1 (Source: Reuters: Health)
Source: Reuters: Health - April 20, 2024 Category: Consumer Health News Source Type: news
Inside Novo Nordisk, the Company Behind Ozempic and Wegovy
Novo Nordisk ’s factories work nonstop turning out Ozempic and Wegovy, its blockbuster weight-loss drugs, but the Danish company has far bigger ambitions. (Source: NYT Health)
Source: NYT Health - April 20, 2024 Category: Consumer Health News Authors: Eshe Nelson and Charlotte de la Fuente Tags: Drugs (Pharmaceuticals) Semaglutide (Drug) Weight Ozempic (Drug) Prices (Fares, Fees and Rates) Obesity Workplace Environment Insulin Novo Nordisk A/S Sanders, Bernard Denmark Jorgensen, Lars Fruergaard Wegovy (Drug) Source Type: news
Time-Restricted Eating Tied to Modest Weight Loss
(MedPage Today) -- Restricting daily eating to a 10-hour window was no silver bullet for boosting weight loss in people with obesity and prediabetes, a small study found.
In the 12-week trial, both time-restricted eating (TRE) and a usual pattern... (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - April 19, 2024 Category: Cardiology Source Type: news
Ozempic baby boom: Doctors are prescribing weight-loss drugs off-label for fertility - with women in their 40s falling pregnant naturally
Doctors have begun doling out Ozempic to women struggling to get pregnant, creating a baby boom. Doctors do not have conclusive evidence yet that it is a viable treatment for infertility. (Source: the Mail online | Health)
Source: the Mail online | Health - April 19, 2024 Category: Consumer Health News Source Type: news
Calories, Not Meal Timing, Key to Weight Loss: Study
FRIDAY, April 19, 2024 -- A head-to-head trial of obese, pre-diabetic people who ate the same amount of daily calories -- with one group following a fasting schedule and the other eating freely -- found no difference in weight loss or other health... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - April 19, 2024 Category: General Medicine Source Type: news
Hundreds of websites are selling fake Ozempic, says company. Doctors say it's only going to get worse
A cybersecurity company says it took down more than 250 websites selling fake versions of diabetes and weight-loss drugs like Ozempic in 2023. Health-care workers say it's growing problem tied to accessibly, affordability and stigma. (Source: CBC | Health)
Source: CBC | Health - April 19, 2024 Category: Consumer Health News Tags: Radio/As It Happens Source Type: news
